149 related articles for article (PubMed ID: 16124759)
1. Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.
Pettit GR; Anderson CR; Gapud EJ; Jung MK; Knight JC; Hamel E; Pettit RK
J Nat Prod; 2005 Aug; 68(8):1191-7. PubMed ID: 16124759
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
Pettit GR; Anderson CR; Herald DL; Jung MK; Lee DJ; Hamel E; Pettit RK
J Med Chem; 2003 Feb; 46(4):525-31. PubMed ID: 12570374
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
Pettit GR; Grealish MP; Jung MK; Hamel E; Pettit RK; Chapuis JC; Schmidt JM
J Med Chem; 2002 Jun; 45(12):2534-42. PubMed ID: 12036362
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of amide isosteres of schweinfurthin-based stilbenes.
Stockdale DP; Beutler JA; Wiemer DF
Bioorg Med Chem; 2017 Oct; 25(20):5483-5489. PubMed ID: 28866376
[TBL] [Abstract][Full Text] [Related]
7. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E
Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
[TBL] [Abstract][Full Text] [Related]
12. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 Aug; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
13. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
Bai R; Friedman SJ; Pettit GR; Hamel E
Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
Pettit GR; Toki BE; Herald DL; Boyd MR; Hamel E; Pettit RK; Chapuis JC
J Med Chem; 1999 Apr; 42(8):1459-65. PubMed ID: 10212132
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.
Pettit GR; Grealish MP; Herald DL; Boyd MR; Hamel E; Pettit RK
J Med Chem; 2000 Jul; 43(14):2731-7. PubMed ID: 10893310
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10.
Bai RL; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Oct; 40(8):1859-64. PubMed ID: 2242019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
